Beranda › Miastenia Gravis › Ohio › Cincinnati
Uji klinis Miastenia Gravis di Cincinnati, OH
5 studi untuk Miastenia Gravis mencari peserta di lokasi sekitar Cincinnati (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
Menerima pesertaStudi observasional
- University of Cincinnati Medical Center - Goodman St, Cincinnati
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
Menerima pesertaFase 2
- University of Cincinnati Medical Center - Goodman St, Cincinnati
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Menerima pesertaFase 3
- University of Cincinnati, Cincinnati
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Menerima pesertaFase 3
- Site Number - 1038, Cincinnati
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Menerima pesertaFase 3
- University of Cincinnati Health Physicians - Clifton, Cincinnati
Uji klinis Miastenia Gravis di kota lain
- Tampa, FL12 studi
- Houston, TX11 studi
- Durham, NC10 studi
- Boca Raton, FL10 studi
- Columbus, OH8 studi
- Milwaukee, WI7 studi
- St. Louis, MO7 studi
- New York City, NY7 studi
- Miami, FL7 studi
- Jacksonville, FL6 studi
- Chattanooga, TN6 studi
- Boston, MA6 studi
Studi lain di Cincinnati
- Kanker Paru Non-Sel Kecil35 studi
- Kanker (semua jenis)27 studi
- Kanker Payudara25 studi
- Gagal Jantung24 studi
- Kanker Kolorektal21 studi
- Leukemia Mieloid Akut20 studi
- Kanker Metastatik20 studi
- Kanker Ovarium19 studi
- Kanker Paru19 studi
- Obesitas19 studi
- Kanker Prostat18 studi
- Mieloma Multipel17 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.